Profound Medical
PROF
56 hedge funds and large institutions have $170M invested in Profound Medical in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 4 closing their positions.
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
38% more capital invested
Capital invested by funds: $124M → $170M (+$46.8M)
27% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $1.97M
24% more funds holding
Funds holding: 45 → 56 (+11)
5.75% more ownership
Funds ownership: 36.34% → 42.09% (+5.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$14.6M |
| 2 |
RA
Royce & Associates
New York
|
+$5.35M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.54M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$3.17M |
| 5 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$2.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$7.94M |
| 2 |
RI
RTW Investments
New York
|
-$2.25M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$1.84M |
| 4 |
Renaissance Technologies
New York
|
-$1.07M |
| 5 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$539K |
PROF Hedge Fund Activity: Q4 2020 in Review
56 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2020, worth a combined $170M — up 38% from $124M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PROF positions and 4 closed out — a net gain of 11 holders — while 18 added to existing stakes and 13 trimmed.
The largest buyer was Letko, Brosseau & Associates, adding an estimated $14.6M. The largest seller was Park West Asset Management, exiting entirely with an estimated $7.94M sold.
- 56 institutional investors held Profound Medical (PROF) as of Q4 2020, up from 45 in Q3 2020.
- Funds reported $170M of Profound Medical stock for Q4 2020, up 38% quarter-over-quarter.
- 15 funds opened new Profound Medical positions in Q4 2020 and 4 closed out, a net change of +11 holders.
- The largest Profound Medical buyer in Q4 2020 was Letko, Brosseau & Associates, an estimated $14.6M added.
- The largest Profound Medical seller in Q4 2020 was Park West Asset Management, an estimated $7.94M sold.
Based on aggregated 13F filings for Q4 2020.